Ishikawa N, Kojima H, Nakayama T, Kunikane H, Hawkin S, Fukasawa Y, Ikeda H, Ogasawara K, Kasahara M, Tajima Y
Immunogenetics. 1987;26(3):143-9. doi: 10.1007/BF00365903.
A monoclonal antibody (mAb) with a novel human B-cell allospecificity was produced by immunizing a C3H/He mouse with the human B lymphoblastoid cell line EBV-Wa (HLA-DR4/Dw15/DQblank homozygous). The mAb, termed HU-46, reacted with B cells from not only DR4/Dw15-positive individuals but also certain DRw8/Dw8-positive ones whose DQ phenotypes had not yet been defined. Two-dimensional gel analyses indicated that the mAb recognized class II antigens which were encoded by the HLA-DQ locus. Furthermore, in genetic analysis, the gene encoding the class II antigen detected by HU-46 met the Hardy-Weinberg condition as a fourth allele of the DQ locus. We provisionally labeled this novel DQ specificity DQWa.
用人类B淋巴母细胞系EBV-Wa(HLA-DR4/Dw15/DQ空白纯合子)免疫C3H/He小鼠,产生了一种具有新型人类B细胞同种特异性的单克隆抗体(mAb)。该单克隆抗体命名为HU-46,不仅与DR4/Dw15阳性个体的B细胞反应,还与某些DQ表型尚未确定的DRw8/Dw8阳性个体的B细胞反应。二维凝胶分析表明,该单克隆抗体识别由HLA-DQ基因座编码的II类抗原。此外,在遗传分析中,由HU-46检测到的编码II类抗原的基因作为DQ基因座的第四个等位基因符合哈迪-温伯格条件。我们暂时将这种新型DQ特异性标记为DQWa。